Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

By L. Iles, H. Pfluger, A. Phrommintikul, Joshi Cherayath, P. Aksit, Sandeep N. Gupta, D. Kaye, A. Taylor. Journal of the American College of Cardiology, 2008

765 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/690015330827f665666d7554fafd028f61d8a2a4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Peter Kellman
2. L. Badano
3. T. Marwick
4. P. Lancellotti
5. T. Force

In Radiology, Nuclear Medicine and Imaging

1. Peter Kellman
2. Michael S. Hansen
3. T. Marwick
4. David A. Bluemke

Citations in the corpus

• Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (2014, methodology): “More recently, gadolinium-based contrast has also been used in T1 mapping, a novel, quantitative CMR technique that identifies subtle myocardial abnormalities such as diffuse fibrosis, not visible on LGE imaging.(228,229) One recent study in a small cohort of 13 patients after anthracycline therapy ”
• Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (2014, methodology): “More recently, gadolinium-based contrast has also been used in T1 mapping, a novel, quantitative CMR technique that identifies subtle myocardial abnormalities such as diffuse fibrosis, not visible on LGE imaging.(228,229) One recent study in a small cohort of 13 patients after anthracycline therapy ”
• Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing (2013, background): “– can account for spatial variations in coil sensitivity c) T1 mapping: [46-49] – may be helpful in identifying diffuse myocardial fibrosis – may provide a quantitative assessment of the extent of fibrosis”
• Dilated Cardiomyopathy (2007, neutral): “Native T1 and ECV are increased, and post-contrast T1 is decreased in nonischemic DCM patients [81, 83, 84].”
• Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold (2010, background): “Focal and global T1 changes are reported in a number of myocardial diseases, such as myocardial infarction [2,3], heart failure [4], valvular heart disease [5], and systemic diseases with cardiac involvement such as amyloidosis [6,7] or systemic lupus erythematosus [8].”
• T1-mapping in the heart: accuracy and precision (2014, methodology): “Inversion Recovery (IR) Multiple breath-hold FLASH [30]”
• Normal values for cardiovascular magnetic resonance in adults and children (2015, neutral): “Iles (2008) [77] 20 38 ± 3 50 GE, VAST 3–4 BH 0.”
• Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement (2013, background): “contrast T1 [70,71] which does not vary linearly with GBCA concentration.”
• Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (2011, methodology): “Different CMR acquisition sequences have been used to obtain myocardial T1 maps (6,75,92,94,95).”